About Shahzad Malik
Shahzad Malik filed with the SEC as director of Acutus Medical from 2020 to 2021.
Form D filings name Shahzad Malik as a director at Nalu Medical.
Shahzad Malik reports to the SEC as a director or major shareholder of 7 public companies, including Iterum Therapeutics plc (ITRM), Aravive (ARAV) and Axonics (AXNX).
Shahzad Malik first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Shahzad Malik in the role, so the role may have started earlier or lasted longer.
AI
Acutus Medical, Inc.
Director
2020 – 2021 · Public company (AFIB)
IP
Iterum Therapeutics plc
Director
2018 – 2020 · Public company (ITRM)
AI
Aravive, Inc.
Director and 10% owner
2014 – 2019 · Public company (ARAV)
AI
Axonics, Inc.
Director and 10% owner
2018 · Public company (AXNX)
HI
Histogen Inc.
Director and 10% owner
2013 – 2016 · Public company (HSTO)
AI
Agenus Inc.
Director
2014 – 2016 · Public company (AGEN)
EI
Emergent BioSolutions Inc.
Director
2006 – 2007 · Public company (EBS)
Key Colleagues at Startups
The people Shahzad Malik works with at each company, as listed on that company's latest Form D.
Nalu Medical, Inc. · Form D, Jul 10, 2015
KH
Keegan Harper
Executive officer and director
SM
Scott Murano
Secretary
MP
Michael Partsch
Executive officer and director
Juliet Bakker
Director